Work

The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer

Year: 2025

Type: article

Study design: Observational Study

Source: Expert Review of Anticancer Therapy

DOI: 10.1080/14737140.2025.2490289

Authors: Furkan Ceylan, Safa Can Efil, Didem Şener Dede, Ates Kutay Tenekeci, Burak Bilgin, Şebnem Yücel, Eren Göktuğ Ceylan, Mutlu Hızal, Mehmet Ali Nahit Şendur, Muhammed Bülent Akıncı, Öznur Bal, Bülent Yalçın

Institutions: Sağlık Bilimleri Üniversitesi, Ankara Yıldırım Beyazıt University, Hacettepe University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409308524

FWCI: 1.177

Cites: 34

Cited by: 2

Related to: 10